Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Neuroscience. Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology.
The typical case for the fund is to invest in rounds with 5 participants. Despite the Baranco, startups are often financed by Juno Capital Partners, Spark Ventures, Nigel Rudd. The meaningful sponsors for the fund in investment in the same round are Revera Home Health Business, Nissha Co., Ltd., Juno Capital Partners. In the next rounds fund is usually obtained by Barvest Ventures.
The top activity for fund was in 2017. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| AL Trust | - |
| Allplan | Bayern, Germany, Munich |
| Avenue Growth Partners | District of Columbia, United States, Washington |
| Avoro Capital Advisors | New York, New York, United States |
| Blueflame Capital | China, Qingdao, Shandong |
| Brandify | Anaheim, California, United States |
| D2C&Co. | Japan, Tokyo |
| Elm Spring | - |
| Good AI Capital | California, Menlo Park, United States |
| Impress Group | Japan, Tokyo |
| Junxin Yingtai Investment | China, Guangdong Province, Yuexiu District |
| Marigold Capital | Canada, Ontario, Toronto |
| NewHold Enterprises | New York, New York, United States |
| NY Group Partners | - |
| Peak Ridge AgTech Fund | Boston, Massachusetts, United States |
| Pioneer Fund | California, San Francisco, United States |
| Seier Capital | Bern, Berne, Switzerland |
| STC Ventures | Dubai, United Arab Emirates |
| TCR Capital | France, Ile-de-France, Paris |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xenocor | $10M | 18 Apr 2023 | Salt Lake City, Utah, United States | ||
Sky Medical Technology | $13M | 01 Sep 2017 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xenocor | $10M | 18 Apr 2023 | Salt Lake City, Utah, United States | ||
Sky Medical Technology | $13M | 01 Sep 2017 | England |
